Evogene Ltd. current report, Q2 FY2016

Business Context and Reporting Period

This Form 6-K filing by Evogene Ltd. covers the month of June 2016. The document serves as a report of a foreign private issuer and incorporates by reference the Proxy Statement for the 2016 Annual General Meeting of shareholders and the Form of Proxy Card.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance materials rather than financial performance data.

Material Changes

The filing text does not provide a clear value regarding material changes versus the prior comparable period.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the submission of proxy materials for the annual shareholder meeting.

Key Facts for Investors to Verify

  • Review the attached Proxy Statement (Exhibit 99.1) for details on the 2016 Annual General Meeting agenda and proposals.
  • Verify the date and location of the Annual General Meeting as outlined in the incorporated exhibits.
  • Confirm the voting procedures and proxy card instructions provided in Exhibit 99.2.